[Chronic liver diseases. The nihilism has gone].
Koczorek
M
M
D000547:Amantadine / Q000008:administration & dosage / Q000627:therapeutic use; D000975:Antioxidants / Q000627:therapeutic use; D000998:Antiviral Agents / Q000008:administration & dosage / Q000627:therapeutic use; D002908:Chronic Disease; D004151:Dipeptides / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005442:Flumazenil / Q000627:therapeutic use; D018757:GABA Modulators / Q000627:therapeutic use; D006501:Hepatic Encephalopathy / Q000188:drug therapy; D019698:Hepatitis C, Chronic / Q000188:drug therapy; D006801:Humans; D007372:Interferons / Q000008:administration & dosage / Q000627:therapeutic use; D008103:Liver Cirrhosis / Q000188:drug therapy; D008107:Liver Diseases / Q000188:drug therapy*; D010431:Pentoxifylline / Q000008:administration & dosage / Q000627:therapeutic use; D010726:Phosphodiesterase Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use; D011446:Prospective Studies; D020011:Protective Agents / Q000627:therapeutic use; D012254:Ribavirin / Q000008:administration & dosage / Q000627:therapeutic use; D012838:Silymarin / Q000627:therapeutic use
D000975:Antioxidants; D000998:Antiviral Agents; D004151:Dipeptides; D018757:GABA Modulators; D010726:Phosphodiesterase Inhibitors; D020011:Protective Agents; D012838:Silymarin; D005442:Flumazenil; D012254:Ribavirin; D007372:Interferons; D000547:Amantadine; C002939:ornithylaspartate; D010431:Pentoxifylline